Inventor
Devleena M. SHIVAKUMAR
Inventor
US
Overview
Patents· 6 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes25%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations25%
C07DHeterocyclic compounds25%
C07BGeneral methods of organic chemistry8%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C12NMicroorganisms or enzymes8%
PatentTitleYear
12,227,520Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use202512,168,002Heterocyclic carboxylate compounds as glycolate oxidase inhibitors202412,054,496Bridged tricyclic carbamoylpyridone compounds and uses thereof202412,024,528Bridged tricyclic carbamoylpyridone compounds and uses thereof202411,806,335Heterocyclic carboxylate compounds as glycolate oxidase inhibitors202311,548,902Bridged tricyclic carbamoylpyridone compounds and their pharmaceutical use2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to GILEAD SCIENCES INC (4)· patent assignee history
2023–2024Patents assigned to LILAC THERAPEUTICS INC (2)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GILEAD SCIENCES INC | 4 | 2023–2025 |
| LILAC THERAPEUTICS INC | 2 | 2023–2024 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 6 | 2023–2025 |